Magnetic resonance imaging (MRI), a technique that has had a truly revolutionary impact on many areas of clinical medicine,1 is starting to be appreciated by the dermatologic community. In this issue of the Archives, Truhan and Filipek2 describe central nervous system MRI findings in patients with neurofibromatosis, tuberosclerosis, and Sturge-Weber syndrome. This is a comprehensive and well-written review on the subject. However, as the authors point out, in the majority of neurocutaneous syndromes, "consistent characteristic CNS findings by MRI have not yet been described."2 For example, central nervous system MRI findings in patients with hypomelanosis of Ito are still poorly characterized and are inconsistent.3,4 The use of MRI surface coils permits direct evaluation and characterization of dermatologic conditions by MR techniques. The evaluation of cutaneous diseases by MR techniques can be subdivided into three areas: (1) the evaluation of skin tumors by MRI using standard commercially
Zemtsov A, Dixon L. Magnetic Resonance in Dermatology. Arch Dermatol. 1993;129(2):215–218. doi:10.1001/archderm.1993.01680230099015
Customize your JAMA Network experience by selecting one or more topics from the list below.